Deakin University
Browse

NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS

conference contribution
posted on 2018-11-01, 00:00 authored by Mustafa Khasraw, Kerrie McDonald, Sonia Yip, Roel Verhaak, Amy Heimberger, Merryn Hall, Lauren Fisher, Elizabeth Barnes, Mark Rosenthal, Craig Gedye, Elizabeth Hovey, Benjamin Ellingson, John Simes, Annette Tognela, Eng-Siew Koh, Hui Gan, Michael Back, Zarnie Lwin
NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS

History

Volume

20

Pagination

235-235

Location

New Orleans, LA

Start date

2018-11-14

End date

2018-11-18

ISSN

1522-8517

eISSN

1523-5866

Language

English

Author URL

Publication classification

E3 Extract of paper

Title of proceedings

NEURO-ONCOLOGY

Event

23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference

Publisher

OXFORD UNIV PRESS INC

Usage metrics

    Research Publications

    Categories

    Keywords

    Science & TechnologyLife Sciences & BiomedicineOncologyClinical NeurologyNeurosciences & Neurology

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC